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Optoactivation of Locus Ceruleus Neurons Evokes
Bidirectional Changes in Thermal Nociception in Rats
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Japan, 4Wellcome Trust Sanger Institute, Cambridge CB10 1SA, United Kingdom, and 5Sorbonne Universite´s, Universite´ Pierre et Marie Curie Paris 6, Unite´
Mixte de Recherche-Scientifique 8246, Neuroscience Paris Seine, Navigation Memory and Aging team, F-75005 Paris, France
Pontospinal noradrenergic neurons are thought to form part of a descending endogenous analgesic system that exerts inhibitory influ-
ences on spinal nociception. Using optogenetic targeting, we tested the hypothesis that excitation of the locus ceruleus (LC) is antinoci-
ceptive. We transduced rat LC neurons by direct injection of a lentiviral vector expressing channelrhodopsin2 under the control of the
PRS promoter. Subsequent optoactivation of the LC evoked repeatable, robust, antinociceptive (4.7°C 1.0, p 0.0001) or pronoci-
ceptive (4.4°C  0.7, p  0.0001) changes in hindpaw thermal withdrawal thresholds. Post hoc anatomical characterization of the
distribution of transduced somata referenced against the position of the optical fiber and subsequent further functional analysis showed
that antinociceptive actions were evoked from a distinct, ventral subpopulation of LC neurons. Therefore, the LC is capable of exerting
potent, discrete, bidirectional influences on thermal nociception that are producedby specific subpopulations of noradrenergic neurons.
This reflects an underlying functional heterogeneity of the influence of the LC on the processing of nociceptive information.
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Introduction
The degree of pain perceived in response to a given noxious stim-
ulus is greatly influenced by the context within which the injury
occurs (Melzack et al., 1982). In part, this variation in perception
is due to differential engagement of endogenous analgesic mech-
anisms within the CNS that act to modulate pain (Ossipov et al.,
2010). Since the original report that electrical stimulation of
the midbrain produces profound analgesia (Reynolds, 1969),
much attention has been focused on descending control sys-
tems, which can influence the spinal transmission of noxious
inputs (Millan, 2002; Fields, 2004). The noradrenaline (NA)-
containing neurons of the locus ceruleus (LC) and the A5 and
A7 cell groups in the pons have been implicated as key com-
ponents of this descending control system (Jones, 1991; Per-
tovaara, 2006).
Although the LC sends projections throughout the neuraxis,
most pain studies have concentrated upon the axonal projections
to the spinal dorsal horn. These have been shown to release NA
(Crawley et al., 1979; Hentall et al., 2003) that acts via 2-
adrenoceptors to inhibit both primary afferents and second order
projection neurons (Reddy et al., 1980; Hammond and Yaksh,
1984; North and Yoshimura, 1984; Jones and Gebhart, 1986b;
Miller and Proudfit, 1990; Kawasaki et al., 2003; Sonohata et al.,
2004). Electrical or chemical stimulation of the LC has been
shown to be analgesic in a number of acute pain models (Jones
and Gebhart, 1986a, 1986b; Miller and Proudfit, 1990; Jones,
1991;West et al., 1993). In addition, in chronic neuropathic pain
models, there are plastic changes in the NAergic innervation of
the spinal dorsal horn (Hughes et al., 2013) and increases in
2-adrenoceptor sensitivity (Ma and Eisenach, 2003; Hayashida
et al., 2008).
Despite this knowledge of the analgesic potential of the pon-
tospinal NAergic system; the use of systemic 2-adrenergic ago-
nists to mimic its action in the treatment of pain is limited by a
confounding side effect profile including sedation and hypoten-
sion (Pertovaara, 2006). The sedation can be reduced by long-
term intrathecal infusion (Hassenbusch et al., 2002), but this is
reserved for the most severe patients because it is expensive to
deploy and can be associated with complications. Similarly, NA
reuptake inhibitors, although moderately efficacious for chronic
pain (Finnerup et al., 2010), are likewise limited by side effects
that are largely a consequence of interactions with other central
NAergic functions. Therefore, the potential of the descending
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NAergic system to suppress pain has not been successfully har-
nessed therapeutically.
We have demonstrated previously that pontospinal NAergic
neurons can be selectively and effectively retrogradely trans-
duced using an adenoviral vector with a catecholaminergic-
selective promoter (Howorth et al., 2009a) and that their
inhibition, through expression of a potassium conductance, can
produce thermal and inflammatory hyperalgesia (Howorth et al.,
2009b). Here, we tested the hypothesis that direct activation of
NAergic neurons of the LC using a selective lentiviral vector
(LV)-mediated optogenetic approach produces analgesia. We
show that activation of the LC can exert potent and temporally
discrete antinociceptive and pronociceptive effects on the re-
sponse to thermal stimulation. These contrasting actions are elic-
ited from different subgroups of the neurons, indicating an
underlying functional heterogeneity of the influence of the LC on
the processing of nociceptive information.
Materials andMethods
Experimental procedures. Experiments were performed on male Wistar
rats. All procedures conformed to the UK Animals (Scientific Proce-
dures) Act of 1986 and were approved by our institutional ethical review
committee. Animals were housed under a standard 12 h light/dark cycle
with ad libitum access to food and water.
LV constructs and preparation. The study used twoLV vectors: LV-sPRS-
hChR2 (H134R)-EYFP and LV-sPRS-hChR2(H134R)-mCherry, differing
only in the fluorophore fused to the human codon-optimized H134R
variant ofChannelRhodopsin2 (ChR2; Fig. 1A; Boyden et al., 2005). Both
LVs use the 240-bp PRSx8 promoter sequence (Hwang et al., 2001) that
restricts the expression of the transgene to a subset of neurons that ex-
press the Phox2 transcription factor, which are predominantly cat-
echolaminergic (Tiveron et al., 1996; Brunet and Pattyn, 2002). We used
a transcriptional amplification strategy (Liu et al., 2006) to enhance ex-
pression of the ChR2 (sPRS). The methods for LV production were as
described previously in detail (Coleman et al., 2003; Hewinson et al.,
2013). In short, this is anHIV-1-based vector pseudotypedwith vesicular
stomatitis virus glycoprotein. The LVs were produced by cotransfection
of Lenti-X293T cells (Clontech) with the shuttle vector pTYF-sPRS-
hChR2(H134R)-EYFP or pTYF-sPRS-hChR2(H134R)-mCherry, along
with a packaging vector, pNHP, and the envelope plasmid pHEF-VSVG.
The virus was collected from the supernatant and concentrated by ultra-
centrifugation. The titer, measured in transducing units (TU)/ml, was
assayed for each batch by establishing the infection rate of an LV pro-
duced in parallel and expressing placental alkaline phosphatase (Hewin-
son et al., 2013). The LV was used undiluted for microinjection at a titer
of 2–3 1010 TU/ml depending upon the batch (4 batches were used in
the course of the experiments).
Pontine LV injection. Stereotaxic injections of LVs were made into the
dorsal pons in the regionof theLC.Theprocedures for viral vector injections
have been described in detail previously (Lonergan et al., 2005; Howorth et
al., 2009a). In brief, rats were anesthetized (intramuscularly or intraperito-
neally) with ketamine (5mg/100 g, Vetalar; Pharmacia) andmedetomidine
(30 g/100 g, Domitor; Pfizer) until loss of paw withdrawal reflex. The
animal was placed in a stereotaxic frame and core temperature was
maintained at 37°C using a homeothermic blanket (Harvard Appara-
tus). Aseptic surgical techniques were used throughout.
To transduce LC neurons directly before pontine brain slice/working
heart brainstem (WHBP) preparations, LV injections were made into
postnatal day 17 (P17)–P19 Wistar rats using a microcapillary pipette
(calibrated in 1 l intervals; Sigma) with a tip diameter of 20 m back-
filled with vector (Fig. 1A). Unilateral or bilateral injections (each 250
mapart in the dorsoventral axis) of LV (250 nl/per injection of LV over
2 min) were made at 4 sites along a single track with the following coordi-
nates: 1 mm, L 1 mm, 4.5–5.5 mm below the brain surface. All WHBP
experiments and the initial pontine slice experiments (n3)weredonewith
the LV-sPRS-hChR2(H134R)-EYFP; the mCherry-expressing vector was
used for the remainder of the slice experiments because this allowed the
neurons to be visualized without activation of ChR2.
To transduce LC neurons before cutaneous thermal stimulation, in-
jections of LVweremade inWistar rats (250–275 g,n 37; Charles River
Laboratories) at the following coordinates:  2.1 mm, L 1.2 mm, and
3 injections of LV (300 nl) at 5.5–6.0mmdeep from brain surface with
a 10° rostral angulation. After LV injection, a guide cannula was im-
planted over the injection site (C313G; Plastics One) and secured to the
skull with dental cement/skull screw (Zhang et al., 2010). The guide
cannula was closed with a dummy cap until the time of the experi-
ment between 2 and 3 weeks after transduction. Sixty-three percent of
the animals used in heat ramp experiments received LV-sPRS-
hChR2(H134R)-mCherry and 37% received LV-sPRS-hChR2(H134R)-
EYFP. There was no difference in the proportion of animals showing
antinociception versus pronociception with the different vectors.
After injections/implantation, anesthesia was reversed with atipam-
ezole (Antisedan, 0.1mg/100 g, i.p.; Pfizer) and buprenorphinewas given
for pain relief (Temgesic, 2 g/100 g, s.c.; Schering-Plough). Animals
showed a rapid functional recovery from anesthesia and surgery.
Pontine slices. Pontine slices were prepared from juvenile Wistar rats
(P24–P40, n 13, 1–3 weeks after LV transduction), which were termi-
nally anesthetized with halothane before decapitation. The brainstem
was removed and bathed in ice-cold cutting solution (similar to the
recording solution but NaCl was reduced to 85 mM and substituted with
sucrose 58.4mM). Slices of the pons were cut (250–350m thick coronal
or longitudinal) using a vibratome (Linearslicer Pro 7; DSK) in cold
(4°C) cutting solution. Slices were kept at room temperature in carboge-
nated recording solution (composition is provided in the “Electrophys-
iology” section below) for at least 1 h before recording.
Electrophysiology. Pontine slices were transferred into the recording
chamber of an upright fluorescencemicroscope (DMLFSA; LeicaMicro-
systems), superfused with artificial CSF containing the following (in
mM): 126 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 MgCl2, 2 CaCl2,
and 10 D-glucose saturated with 95%O2/5%CO2, pH 7.3, osmolality 290
mOsm/L, 35°C at a rate of 2–3 ml min1. Patch pipettes (resistances of
4–6 M) were filled with internal solution containing the following (in
mM): 130 K-gluconate, 10 KCl, 10 Na-HEPES, 4MgATP, 0.2 EGTA, and
0.3 Na2GTP. All membrane potentials were corrected for a junction po-
tential of 13 mV. Fluorescent transduced LC neurons (EYFP/mCherry)
were identified and whole-cell recordings were then obtained under gra-
dient contrast illumination (Dodt andZieglga¨nsberger, 1990).Once con-
firmed as fluorescent, the cells were not exposed to epilumination via the
objective until after the whole-cell patch-clamp recordings were com-
pleted. Recordings were made in current-clamp or voltage-clamp mode
and current pulses were injected to examine the current-voltage and
current-spike frequency relationships (Axopatch 1D amplifier; Molecu-
lar Devices). The signal was filtered at 3 kHz, digitized at 10 kHz, and
stored using Spike 2 software (Cambridge Electronic Design). Light was
pulsed onto the cells (0.1–5 mW for 20 ms to 10 s) using a focally placed
optical fiber proximate to the recorded cell (400 m in diameter) pig-
tailed to a 473 nm LED source (Doric).
WHBP. TheWHBP was used to examine the responses of LC neurons
to optoactivation in an in vivo-like preparation. Preparations were made
from LV-transduced Wistar rats aged 24–30 d (n  6) according to
previously publishedmethods (Paton, 1996; Pickering et al., 2003;McAl-
len et al., 2011). In brief rats, were deeply anesthetized with halothane,
bisected subdiaphragmatically, exsanguinated, cooled by immersion in
5–10°C Ringer’s solution containing the following (inmM): 125NaCl, 24
NaHCO3, 3 KCl, 2.5 CaCl2, 1.25 MgSO4, 1.25 KH2PO4, and 10 dextrose,
pH 7.35–7.4 after carbogenation, before a precollicular decerebration
and cerebellectomy to expose the dorsal surface of the pons. While still
cold, the phrenic nerve and descending aorta were dissected free and a
bilateral pneumonectomy was performed. The preparation was then
transferred to a recording chamber and retrogradely perfused with
Ficoll-70 (1.25%) containing carbogenated aCSF (32°C) through a dou-
ble lumen cannula inserted into the descending thoracic aorta. As the
preparation warmed and brainstem perfusion was reestablished, respira-
tory movements returned and the preparation was paralyzed with vecu-
ronium (2 g/ml). Preparation viability was assessed by the presence of
Hickey et al. • Bidirectional Modulation of Nociception by LC J. Neurosci., March 19, 2014 • 34(12):4148–4160 • 4149
ramping phrenic nerve discharge recorded with a suction electrode and
robust responses to cardiorespiratory reflex activation.
Extracellular recordings were made (using a custom-built AC ampli-
fier) from neurons in the LC using glass microelectrodes filled with 1 M
NaCl (resistance 8–15M). The signal was band-pass filtered (200Hz to
3 kHz), digitized at 10 kHz (micro1401; Cambridge Electronic Design),
and stored on a PC for analysis with Spike2 software. Neurons were
optoactivated by light pulses (445 nm diode laser, Omicron Phoxx,
0.1–15 mW, 10 ms to 10 s) from an optical fiber (200 m core, multi-
mode; Thorlabs) placed over the dorsal surface of the pons or inserted up
to 300 m into the tissue. At the end of the experiment, pontine tissue
was fixed in 4%paraformaldehyde for 48 h before sucrose cryoprotection
A
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Figure 1. Selective and functional expression of hChR2 in rat locus ceruleus neurons. A, Schematic of experimental approach. LV-sPRS-hChR2(H134R)-mCherry or LV-sPRS-hChR2(H134R)-EYFP
is injected directly into the LC. B, Two weeks after unilateral LC injection of LV-sPRS-hChR2(H134R)-EYFP, there is robust, selective expression in NAergic neuronal somata and processes (arrowed
cells on edge of LC shown magnified beneath). EYFP expression (green), DBH immunoreactivity (red), and overlaid images (right). 4thV, Fourth ventricle. C, Voltage-clamp recordings from
transduced LC neurons in brainstem slices showed inward currents to blue light, showing a characteristic fast desensitization typical of hChR2 (H134R; 473 nm light, 1–5mW, Vhold60 mV). D,
Pulses of blue light (4.5 mW, 50 ms) reliably evoked action potential trains in the same neuron as C at a range of frequencies (up to 10 Hz). E, In some transduced neurons, pulsed illumination (50
ms, 5 mW) only produced subthreshold depolarizations, whereas constant illumination of the same intensity (5 mW) brought the neuron to threshold.
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(30% overnight). Coronal sections were cut on a freezingmicrotome (40
m) and processed for dopamine -hydroxylase (DBH) as described in
Immunohistochemistry, below.
Cutaneous stimulation with heat ramps. LC-transduced (n  37) and
naive Wistar rats (n 12) were anesthetized with isofluorane (1.5–4%)
until loss of paw withdrawal reflex. The external jugular vein was cannu-
lated and the animal was switched to an intravenous anesthetic (Alfax-
alone, 10 mg/ml, 7.5–15 mg/h; Vetoquinol). The carotid artery and
trachea were also cannulated and, for some experiments, an intrathecal
catheter (32 gauge tubing [Recathco] coupled to PE 10 tubing) was in-
serted at the L4–5 interspace through a 25 G needle. The animal was
placed in a stereotaxic frame and EMG wires (Teflon-coated stainless
steel, 75mdiameter; Advent ResearchMaterials) were inserted into the
belly of biceps femoris. The signal was AC amplified (Neurolog NL-104;
Digitimer), band-pass filtered (60 Hz to 5 kHz Neurolog NL125) and
digitized (at 20 kHz) via a micro1401 into Spike2 software (Cambridge
Electronic Design).
Once the surgical procedures were completed, the anesthetic was
titrated to a stable, lighter plane of anesthesia until a withdrawal reflex
could be evoked by moderate pinch of the forepaw. Heat ramp stimuli
were applied to the dorsal surface of the left hindpaw using a custom-
built thermal heat stimulator consisting of a heating lamp focused on a
copper disc placed in contact with the foot with a surface mounted ther-
mode (McMullan et al., 2004). The rate of heating of the hindpaw was
A
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Figure 2. Optoactivation of locus ceruleus neurons in the working heart brainstem preparation. A, Rats (P21) received a unilateral injection of LV into the LC. After 1–3 weeks, extracellular
recordings were made from LC neurons in a decerebrate (and cerebellectomized), artificially perfused preparation that allows direct access to the floor of the fourth ventricle to study the cells in a
functionally connected network (Paton, 1996). PNA, Phrenic nerve activity; PP, perfusion pressure. B, Action potential trains recorded from a spontaneously active LC neuron expressing LV-sPRS-
hChR2(H134R)-EYFP. Pulsed illumination ( 445 nm, 20 mW, 20 ms pulse, 3–12.5 Hz) over transduced neurons produced temporally precise activation, followed by a refractory period. At higher
stimulus frequencies (	8 Hz), the neuron started to fail to follow each individual stimulus, resulting in a fall in frequency seen in the instantaneous firing frequency plots. C, The same neuron
responded to continuous illumination with a prolonged increase in firing frequency (response to 9 mW shown in the top two panels). This was seen in response to lower light intensities and could
produce ahigher level ofmaintainedneuronal discharge thanpulsed stimulus protocols (instantaneous firing frequencyplots shownoverlaid for stimuli from0.03 to9mW). Itwas also apparent that
the LC neurons show accommodation to the stimulus.
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adjusted to be in the range of 6.5–7.5°C s1.
The temperature at the point of hindlimbwith-
drawal (based on onset of EMG response) was
measured as the output of the assay. Ramps
were applied at 8min intervals tominimize the
risk of sensitization. Three baseline threshold
measures (within 1.5°C of each other) were ob-
tained before light stimulation was tested to
ensure stable recording conditions. Light stim-
uli ( 445 nm, 1–30 mW, pulsed or continu-
ous) were applied via a bare-ended fiber optic
(200 m core, multimode; Thorlabs) lowered
through the implanted guide cannula to a pre-
determined depth just above the left LC (4.5
mm deep to the brain surface). The threshold
of the withdrawal response to heat ramp was
rechecked after changing the fiber position to
ensure that it remained stable before trials of
optoactivation. The optical stimuli were initi-
ated 60 s before application of the heat ramp
and were terminated immediately after the
ramp. If no response was seen (i.e., change in
threshold of 1.5°C) with successive heat
ramps, then the fiber was advanced in 500
m steps to a maximum depth of 6.5 mm. If
no change in threshold was seen on reaching
this depth, then the experiment was ended
(n  11). In three of these experiments, the
post hoc histology showed that the implanted
guide cannula was off target and these were
excluded from further analysis. In the re-
maining eight, there was no evidence of viral
transduction (no fluorophore expression),
but the fiber was correctly targeted to the LC.
These preparations were then used as con-
trols for thermal withdrawal thresholds and
also blood pressure changes.
Extracellular recording. Extracellular record-
ings of LC neurons (ipsilateral to LV injection)
were obtained during preliminary heat ramp
testing. A parylene-c insulated tungstenmicro-
electrode (5 M; A-M systems) referenced
against a sintered silver chloride pellet placed
under the scalp was lowered into the left LC
(5.2–6.5 mm deep to the brain surface). The
signal was amplified (Axon Multiclamp 700A;
Molecular Devices), filtered (100 Hz to 2–3
kHz), and data were collected as described for
theWHBP. Neurons were considered to be LC
if they fit several criteria: (1) a duration of ac-
tion potential 1 ms, (2) spontaneous firing
with a slow firing rate of 0.5–7 Hz, (3) a large amplitude characteristic
action potential waveform, or (4) biphasic response to contralateral
hindpaw pinch with activation followed by a transient silent period (as
described previously; Cedarbaum and Aghajanian, 1978). Extracellular
recordings were used to assay the response of LC cells to noxious thermal
stimuli and then optoactivation. The baseline firing rate (in Hertz) of LC
neurons was measured over a 5 s window (always taken 20 s before start
of either heat or light stimuli). In those preparations (n 5) examining
LC responses to thermal stimuli, LC firing rate (in Hertz) was recorded
over a 5 s time period from the onset of the burst of activity. In
preparations measuring cell responses to optoactivation, the record-
ing electrode was coupled to an optical fiber (150 m core; Thorlabs;
Abbott et al., 2009) with its recording tip 500 m ahead of the fiber
tip. Note that this assembly could not be easily maneuvered down the
implanted guide cannula (usually only one recording track was pos-
sible), so these recordings were not performed routinely in the heat
ramp experiments. Cells were illuminated (445 nm diode laser, Omi-
cron Phoxx, 1–30 mW, continuous 5–30 s) and the change in LC
firing rate was compared with the baseline firing rate taken before
onset of illumination.
Tissue fixation. Rats were killed with an overdose of pentobarbital
(Euthatal, 20 mg/100 g, i.p.; Merial Animal Health) and perfused
transcardially with 0.9% NaCl (1 ml/g) followed by 4% formal-
dehyde (Sigma) in 0.1 M phosphate buffer (PB; pH 7.4, 1 ml/g). The
brain was removed and postfixed overnight before cryoprotection in
30% sucrose. Coronal tissue sections were cut at 40 m intervals
using a freezing microtome and left free floating for fluorescence
immunohistochemistry.
Immunohistochemistry. Tissue sections were washed 3 times in 0.1 M
PB and permeabilized in 50% ethanol for 30min before further washing.
The tissue was incubated on a shaking platform with primary antibodies
against dopamine -hydroxylase (mouse anti-DBH, MAB308, 1:10,000
or 100 ng/ml; Millipore), or EYFP (chicken anti-EGFP, AB13970, 1:5000
or 2 g/ml; Abcam) in PB with 5% horse serum (HS) and 0.3% Triton
X-100 for 12–24 h at room temperature. After further washing, sections
were incubated for 4 hwith appropriate secondary antibodies conjugated
to fluorophores (Alexa Fluor 488 and Alexa Fluor 594 1:1000 or AMCA
A
B
C
D
Figure 3. Response of LC neurons to noxious hindpaw stimuli. A, Extracellular recordings were made from LC neurons in
alfaxalone-anesthetized animals to verify their locationwith reference to the cerebellar surface. Heat ramp stimuliwere applied to
thedorsal surfaceof the left hindpawusinga contact heatdevice (McMullanet al., 2004). EMGactivity (green trace) fromthebiceps
femoriswas used to indicate the onset ofwithdrawal. Pinch stimuliwere also applied to the ipsilateral and contralateral hindpaws.
B, LCneurons (foundat depths 5–6.5mm) showed the characteristic spikewaveform, spontaneous activity, andbiphasic response
(activation-inhibition) to contralateral hindpaw pinch. C, A qualitatively similar but less intense biphasic response was evoked by
ipsilateral hindpaw pinch. D, Application of the heat ramp stimulus to the ipsilateral hindpaw also activated the same LC cell. The
activation occurred only as the skin temperature approached the noxious range,with the increase in firing commencing just before
the withdrawal response.
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1:200) in PB with 2% HS and 0.3% Triton X-100. Sections were washed
three times before mounting. We validated the specificity of the DBH
antibody previously (Howorth et al., 2009a). The anti-EGFP antibody
has been validated by Western blot and immunocytochemistry to be
specific for both EGFP and EYFP (Abcam manufacturer’s datasheet).
Here, it showed an overlapping distributionwith EYFP-positive cell bod-
ies and processes and amplified the signal in distal processes; no staining
was seen in control brainstem tissues without viral vector injection. Neg-
ative controls were routinely run by omitting primary antibodies.
Photomicrography. Representative images were taken on a Zeiss Axios-
kop 2 fluorescence microscope with a Zeiss Axiocam HRC using the
appropriate excitation-emission filter sets (EYFP/Alexa Fluor 488 #10,
mCherry/Alexa Fluor 594 #1 and #5, and AMCA #02). The images were
initially processed using Zeiss software (Axiocam 4.7 software),Zeiss and
prepared for presentationusingAdobePhotoshopCS5withoptimizationof
contrast/brightness as required and the addition of annotation.
Analysis. All data are presented asmean SEMormedian (interquar-
tile range) as appropriate. The normality of data was assessed using the
D’Agostino–Pearson test. Subsequent statistical testing was under-
taken using paired and unpaired t tests, one- and two-way ANOVA
(with Bonferroni’s posttests), and Mann–Whitney/Kruskal–Wallis
(with Dunn’s posttest) tests as appropriate. Data were analyzed using
Prism Version 5 software (GraphPad) and differences were consid-
ered significant at p  0.05.
Results
Selective expression of ChR2 in
noradrenergic LC neurons
Direct stereotaxic injection of LV-sPRS-
hChR2(H134R)-EYFP or LV-sPRS-hChR2
(H134R)-mCherry to the LC produced
selective expression of the fluorophore-
ChR2 construct within LC neurons (Fig.
1A,B). These transduced neurons showed
characteristic membrane-delimited fluo-
rescence with strong signal from the den-
drites and axonal processes, as expected of
the ion channel-fluorophore construct.
The expression was limited to neurons
that were identified as NAergic on the ba-
sis of DBH immunocytochemistry (Fig.
1B). The strength of expression increased,
as judged from the fluorescence intensity
and the extent of visible processes over a
period of 3 weeks.
Functional expression of ChR2 in LC
neurons in vitro
To confirm the functional expression of
hChR2 in the LC, we transduced neurons
by stereotaxic injection of LV 1–3 weeks
before preparing pontine slices. Suc-
cessful transduction of the neurons was
confirmed by the presence of visible fluo-
rescent somata within the boundaries of
the LC in the slice. Current-clamp record-
ings of the transduced fluorescent neu-
rons (n  15) showed typical LC
electrophysiology, indicative of good cel-
lular health, including spontaneous ac-
tion potential discharge, large action
potentials, and a pronounced slow AHP.
Optoactivation evoked inward currents
in voltage clamp (Fig. 1C) that reversed
close to zero and showed a rapid phase
of desensitization, characteristic of
ChR2. Current-clamp recordings showed that light pulses
evoked time-locked depolarizations in all cells and action po-
tential discharge (Fig. 1D). This pattern of optoexcitation was
not seen in neurons that were not fluorescent or in transduced
neurons in response to incident white light illumination. The
charging of the membrane in these LC neurons typically took
20–50 ms before the threshold for spike discharge was
reached. The LC neurons showed accommodation during a
train of pulses with failures of spike discharge to limit the
frequency of repetitive firing (typically to 10 Hz). Both
pulsed and continuous illumination were effective stimuli for
some cells (n  4/6 tested with both stimuli). However, in
several of these LC neurons (n  2/6), only the application of
constant light (or prolonged pulses of duration 	100 ms)
could bring the neuron to threshold, whereas pulsed illumi-
nation (with durations of 50 ms) only produced subthresh-
old depolarizations (Fig. 1E). Furthermore, continuous
illumination consistently increased spike discharge at lower
light intensities than pulsed illumination. In all neurons, the
optoexcitation was followed by a period of neuronal quies-
cence; the magnitude of this silent period was related to the
A
B
Figure 4. Targeting and optoactivation of LC neurons in vivo. A, Position of optical fiber (dotted white line) with respect to the
LC is evident in the bright-field view of the cerebellum and dorsal pons. The fluorescence image of the same section showing LC
neurons transduced with LV-sPRS-hChR2(H134R)-mCherry (red). 4V, Fourth ventricle. Bi, In vivo extracellular recording (with an
optic fiber-electrode combination) from a spontaneously active LC neuron transduced with LV-sPRS-hChR2(H134R)-mCherry.
Continuous illumination (30mW)over the transduced LCproduced repeatable, titratable increases inneuronal discharge, followed
by a period of neuronal silence that is characteristic of LC neurons.Bii, Pooled data showing optoactivation of LC neurons produced
robust increases in cell activity (n 5; *p 0.05, paired t test).
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duration and intensity of prior stimula-
tion, as is characteristic of LC neurons
(Aghajanian et al., 1977).
Functional expression of ChR2 in LC
neurons in the WHBP
The WHBP was used to examine the re-
sponses of LC neurons to optoactivation
in an in vivo-like preparation to test
whether their activity could be driven in a
more intact setting with competing ongo-
ing synaptic drives and compensatory
mechanisms (Fig. 2). Extracellular re-
cordings in the WHBP showed that
pulsed illumination over the transduced
LC could produce temporally locked acti-
vation of neurons (n 6; Fig. 2B). These
extracellularly recorded LCneurons faith-
fully generated action potentials in re-
sponse to pulsed optoactivation (at 1–2
Hz with pulses of 20–30 ms duration, 20
mW). However, for each cell, failures of
optoactivation were observed at higher
stimulus frequencies of between 2 and 10
Hz that limited the maximum discharge
frequency. Constant illumination of the
same neurons produced robust in-
creases in firing frequency (Fig. 2C) at
relatively lower light intensities. Fur-
thermore, the peak firing frequency that
could be attained was higher than that
seen with pulsed stimulation (reaching a
peak of 29 14 Hz, n 5), although, in
every case, theneurons exhibited adegree of
accommodation to these stimuli. As in
slices, the periods of optoexcitation were
followed by a refractory period (7.9 2.1 s)
when spontaneous action potential dis-
charge was inhibited.
LC optoactivation strongly modulates
thermal nociception in vivo
The withdrawal response to a thermal
heat ramp stimulus applied to the hindpaw of anesthetized adult
rats was used to assay the effect of LC optoactivation on nocice-
ption (Fig. 3). Extracellular recordings of LC neurons were made
in vivo to confirm the coordinates for subsequent optoactivation
experiments (n  3 rats) and to characterize their responses to
heat ramp stimuli (n 5 rats). LC neurons were found from 5.0
to 6.5 mm ventral to the cerebellar surface and were recognizable
by their characteristic spike shape, spontaneous activity, and bi-
phasic response to paw pinch, which was characteristically stron-
ger in response to stimuli applied to the contralateral paw
(Cedarbaum and Aghajanian, 1978; Sugiyama et al., 2012). Ap-
plication of heat ramp stimuli to the ipsilateral hindpaw triggered
a phasic burst of firing as the thermal stimulus approached the
noxious range and triggered a withdrawal response in all LC neu-
rons tested (from a baseline mean rate of 2.5  0.7 to 7.2  1.9
Hz, p 0.048, paired t test, n 6 cells; Fig. 3). This increase in LC
firing was immediately followed by a characteristic refractory
period before returning to baseline firing levels after the stimulus.
For the in vivo optoactivation experiments, animals were
transduced with hChR2 by injection of vector 3–4 weeks earlier
and had a guide cannula implanted above the LC to direct the
optical fiber. Lowering a combined optical fiber–tungsten elec-
trode down the cannula (Fig. 4A) allowed the effect of optoacti-
vation to be seen in vivo. LC cells were driven strongly by
continuous illumination (30 mW, firing rate of LC neurons
increased from 2.4 0.7 to 20.4 6.1 Hz, p 0.043, paired t
test, n  5 cells; Fig. 4B), which was consistent with our ob-
servations in the WHBP. In each case, this was followed by a
period of relative quiescence once the illumination ceased, but
the responses were fully recapitulated on repeat optoactiva-
tion. Therefore, based on our in vitro and in situ experiences
with pulsed optoactivation of LV-transduced LC neurons
(showing limited frequency response), we elected to standard-
ize on a continuous illumination protocol for the subsequent
in vivo experiments because this allowed us to more closely
mimic the stimulation protocol (50–100 Hz applied for peri-
ods of up to 1 min) before noxious stimulation used in previ-
ous studies of LC antinociceptive effects (Jones and Gebhart,
1986a, 1986b; Miller and Proudfit, 1990; Jones, 1991; West et
al., 1993).
A
C
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Figure 5. Optoactivationof LCproducesagraded fall in arterial bloodpressure.A, Temporallydiscretedepressor effect on illumination
of the LC (6–30mW, blue box). Arrow indicates blood pressure response to application of the noxious thermal heat ramp stimulus to the
hindpaw. B, Mean arterial blood pressure dropped by	20 mmHg during LC optoactivation in LV-transduced animals compared with
controls (no viral transduction). ***p 0.001 rmANOVA and Bonferroni’s posttest). Ci, With the fiber 4.5mmdeep to the brain surface,
illumination (30 mW) does not cause any change in blood pressure and the thermal withdrawal threshold is unchanged at 53°C. Cii,
Advancing the fiber by 500 m, we now evoke a depressor response, but there is still no change in the withdrawal threshold. Ciii,
Advancingthefiberto its finalposition(5.5mmdeep),weseealargerdepressorresponsenowaccompaniedbyareductioninthethreshold
forwithdrawal. Note thatwith each heat ramp stimulus, there is a corresponding transient pressor effect.
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Optoactivation of the LC produced graded (according to
stimulus intensity and duration), reproducible falls in mean ar-
terial pressure (30 mW, 25  5 mmHg, p  0.0001, repeated-
measures ANOVA [rmANOVA] with Bonferroni’s posttest, n
11; Fig. 5A,B), which was not seen in con-
trol animals (p 	 0.05, n  7). The de-
pressor response was also related to
optical fiber depth such that itsmagnitude
increased as the LC was approached (Fig.
5C). A similar depressor effect has been
seen on microinjection of glutamatergic
or cholinergic agonists (Jones and Geb-
hart, 1986b; Sved and Felsten, 1987) and is
mediated by sympathoinhibition. These
studies contrasted with electrical stimula-
tion of the LC that was found to produce a
pressor effect thought to be due to an off-
target action on fibers of passage. This
depressor effect of LC optoactivation
therefore supports the efficacy/selectivity
of our stimulation methodology.
LC activation exerted a strong antino-
ciceptive effect (seen in 55% of rats, n 
11/20) with repeatable, substantial, in-
creases in thermal withdrawal thresholds
(4.7  1.0°C, p  0.0001, rmANOVA
with Bonferroni’s posttest, n 11/20; Fig.
6A–C). These changes were seen to re-
verse back to baseline within 10 min. No
change in threshold was seen in control
rats in which the same laser stimulus was
applied to the LC (n  8; Fig. 6C). After
repeated optoactivation of the LC (typi-
cally 	3), a prolonged increase in the
withdrawal threshold was sometimes ob-
served that did not recover over the time
course of the experiment (	2 h).
Intrathecal administration of cloni-
dine (0.75 g) also increased the with-
drawal threshold in naive animals (7.8 
0.8°C, p 0.0001, rmANOVA with Bon-
ferroni’s posttest, n  7; Fig. 6D), which
was not seen in saline controls (0.5 
0.5°C, n.s., n 5), demonstrating the sen-
sitivity of the thermal withdrawal assay to
spinal 2-agonists. This action of cloni-
dine was reliably reversed by atipamezole
(50g, i.t.), a selective2-antagonist; clo-
nidine no longer produced a significant
change in withdrawal threshold (1.0 
1.0°C). However, in LC-transduced ani-
mals, atipamezole (100 g, i.t.) failed to
attenuate the LC-evoked antinociception
(8.9 2.2°C, p 0.05, rmANOVAwith
Bonferroni’s posttest, n 4; Fig. 6E), sug-
gesting that this action was not mediated
by spinal 2-adrenoceptors. Indeed, the
atipamezole appeared to prolong the du-
ration of the stimulation-evoked increase
in threshold, which no longer returned to
baseline (within 30 min).
In contrast, 45% of the animals
showed pronociceptive effects on optoac-
tivation of the LC with reversible decreases in thermal threshold
(4.4 0.7°C, p 0.0001, rmANOVA with Bonferroni’s post-
test, n 9/20; Fig. 7). In individual experiments, only an increase
or a decrease in threshold was seen after LC optoactivation at the
A
B C
D E
Figure 6. LC optoactivation is antinociceptive. A, Withdrawal responses to the thermal stimulus with a burst of EMG activity
recorded frombiceps femoris corresponding to awithdrawal threshold of
46°C under baseline conditions (2). Optoactivation
of the LC (30mWfor 60 s before heat ramp, blue box) increased thewithdrawal threshold temperature by 5°C,which fully reversed
back to control 8min later.B, Plot of change inwithdrawal thresholdwith repeated optoactivation (blue bars) fromanother single
experimentwith a returnback tobaselinewithin 10min.C, Pooleddata showingLCoptoactivation to robustly increasewithdrawal
thresholds by	4°C (degrees change from baseline), which is consistent with an antinociceptive action (n 11) compared with
controls (no viral transduction, n 8). D, Intrathecal clonidine (750 ng), an 2-agonist, significantly increased withdrawal
thresholds ( p 0.001, paired t test, n 7), which remained elevated for	30 min. However, this increase in withdrawal
threshold was reversed back to baseline in the group of animals given atipamezole (50g, i.t, n 3, p 0.01, unpaired t test).
E, In contrast, intrathecal atipamezole (100g) didnot prevent the antinociceptive effects of LC optoactivation (n4). rmANOVA
with Bonferroni’s posttest, ***p 0.001, **p 0.01, *p 0.05.
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initial fiber site. We reviewed the experi-
mental parameters for the antinociceptive
versus pronociceptive actions (n 11 and
9, respectively) and there was no differ-
ence in anesthetic infusion rate (alfax-
alone 11.7 0.8 vs 10.0 1.0 mg/h, p
0.17, unpaired t test), which was titrated
against the paw withdrawal response; in
hindpaw skin surface temperature
(27.7  0.5 vs 27.8  0.6°C respectively,
p  0.9, unpaired t test); or in baseline
thermal withdrawal thresholds (49.2 
1.1 vs 51.5 0.3°C, respectively, p 0.13,
unpaired t test). Similarly there was no
difference in themagnitude of the depres-
sor responses to LC activation in prepara-
tions showing antinociceptive (27  4
mmHg, n  7) or pronociceptive actions
(22 9mmHg, n 4, p 0.78, unpaired
t test). The depressor effect was not asso-
ciated with significant changes in hind-
paw skin temperature (27.9  0.4 vs
28.2  0.4°C, p  0.12, paired t test, n 
9). Comparable studies using heat ramps have shown that similar
changes in arterial pressure associated with PAG stimulation
were not responsible for the antinociceptive effects (McMullan
and Lumb, 2006).
Post hoc histological analysis suggested that different sub-
populations of LCneuronswere labeled in those animals showing
antinociceptive effects (with a ventral predominance extending
down to the subceruleus) compared with those showing prono-
ciceptive effects (largely restricted to amore dorsal location in the
body of the LC proper; Fig. 8A). Similarly analysis of the distri-
bution of the successful fiber stimulation sites also demonstrated
that the pronociceptive actions tended to be evoked from amore
dorsal position (5.25  0.2 vs 5.6  0.1 mm, respectively, p 
0.04, unpaired t test; Fig. 8B). Having noted the relationship of
LC-evoked response to the placement of the optical fiber, we
changed our experimental protocol and intentionally advanced
the fiber (by 500m) beyond its initial stimulating position (n
3) and observed a switch from pronociception (3.3  0.1°C,
p 0.05, rmANOVA with Bonferroni’s posttest, n 3) to anti-
nociception (2.9  0.3, p  0.01) as the fiber was moved to a
deeper position (Fig. 8C). In one experiment, this was found to be
reversible back to antinociception onwithdrawal of the fiber back
to its original position.
Discussion
The LC is proposed to play an important role in an endogenous
descending pain control circuit (Jones, 1991; Millan, 2002; Per-
tovaara, 2006). Given that this NAergic circuit component ap-
pears to be functionally underactive in chronic neuropathic pain
(Howorth et al., 2009b; Alba-Delgado et al., 2012; Hughes et al.,
2013), we have been interested in exploring the nature of this
deficit and developing strategies to augment its activity. In this
study, we have tested whether the expression of hChR2 in NAer-
gic neurons (Carter et al., 2010; Zhang et al., 2010) will permit
selective, specific, temporally discrete activation of the LC and
have assessed its role in the control of thermal nociception.
We assayed the effect of LC activation on the nocifensivewith-
drawal response to a hindpaw thermal heat stimulus (McMullan
et al., 2004). Consistent with a role in endogenous analgesia, we
show that activation of the LC can produce a substantial, tempo-
rally discrete antinociceptive effect. We also describe a novel
acute pronociceptive effect of LC activation using similar stimu-
lation parameters and propose that distinct subpopulations of
neurons in the LC drive these opposing actions. These findings
demonstrate bidirectional modulation of nociception by the
LC-a characteristic that has long been known for other brainstem
descending control areas such as the rostral ventromedial me-
dulla (RVM; Heinricher et al., 2009; Ossipov et al., 2010) and the
periaqueductal gray (PAG; Basbaumand Fields, 1978; Lovick and
Bandler, 2005). Bidirectional modulation of nociception has also
been reported previously for the A7 NAergic cell group after mi-
croinjection of opioids (Holden et al., 1999) or GABAA antago-
nists (Nuseir and Proudfit, 2000).
The LC extendswidespread projections and is themain source
of NA for much of the CNS (Dahlstrom and Fuxe, 1964; Foote
and Morrison, 1987; Aston-Jones, 2004). It is a relatively small
structure with
3000 neurons in the rat (Loughlin et al., 1986a)
and, although these cells are considered homogenous with re-
spect to their NAergic neurochemistry, they can be divided into
several different subgroups based on cell morphology and effer-
ent targets (Loughlin et al., 1986b; Berridge and Waterhouse,
2003; Aston-Jones, 2004). With respect to pain control, it is the
descending projections to the spinal dorsal horn that have re-
ceived the most attention (Jones, 1991; Millan, 2002; Pertovaara,
2006) and these are predominantly located in the ventral pole and
in the subceruleus (Westlund et al., 1983; Howorth et al., 2009a;
Bruinstroop et al., 2012). Previous studies have shown that focal
stimulation (electrical and/or chemical) of the LC region can
produce antinociceptive effects (Margalit and Segal, 1979; Jones
andGebhart, 1986b; Jones, 1991;West et al., 1993).We have now
shown directly that LC neuronal activation is antinociceptive
through the use of an optogenetic approach that specifically tar-
gets the NAergic neurons and removes the potential confound of
stimulation of axons of passage or indirect activation of neigh-
boring neurons via chemical spread. Therefore, our findings re-
inforce the notion that the LC is part of the endogenous
antinociceptive control system.
The LC-stimulation induced antinociception was mimicked
by intrathecal administration of the 2-agonist clonidine, but
was not blocked by intrathecal administration of the 2-
A B
Figure 7. Optoactivation of LC neurons can be pronociceptive. Optoactivation of the LC (30mW, 60 s blue box) decreased
thermal withdrawal thresholds in some preparations, suggesting a pronociceptive action (n 9). A, Plot of change in
withdrawal threshold from a single experiment. The drop in withdrawal threshold was repeatable and typically reversed
back toward baseline within 10 min. B, Group data (n  9) showing that withdrawal thresholds were significantly
decreased by LC optoactivation (degrees change from baseline). rmANOVA with Bonferroni’s posttest, ***p  0.001,
**p 0.01, *p 0.05.
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antagonist atipamezole—indeed, this dose appeared to enhance
the antinociceptive action. This is counter to previous reports
showing that intrathecal 2-antagonists block LC-stimulus-
evoked analgesia (Jones andGebhart, 1986b;Miller and Proudfit,
1990; West et al., 1993). We used a substantial dose of atipam-
ezole (100 g) that was double that
needed to completely reverse the effects of
intrathecal clonidine. One previous LC
stimulation study reported analgesic ac-
tions that were resistant to an intrathecal
2-antagonist, idazoxan (West et al.,
1993). It may be relevant to note that ati-
pamezole and idazoxan have a much
higher 2:1 selectivity ratio than yohim-
bine (Pertovaara et al., 2005), which was
used by many of the early studies (Jones
and Gebhart, 1986b; Miller and Proudfit,
1990; West et al., 1993). It remains to be
determined whether the antinociceptive
actions of LC activation may be mediated
by another mechanism, such as enhance-
ment of inhibitory transmission by 1-
receptors at a spinal level (Baba et al.,
2000; Gassner et al., 2009; Funai et al.,
2014). It may also be relevant that the LC
neurons are capable of releasing other
transmitter substances such as galanin,
neuropeptide Y, and ATP in addition to
noradrenaline (Holets et al., 1988); spinal
galanin in particular has been associated
with antinociceptive actions (Hua et al.,
2004). Alternatively, the LC may have a
supraspinal action via a relay in the RVM
(Aston-Jones, 2004) to inhibit the spinal
nociception through opioid release (Mar-
galit and Segal, 1979; Miller and Proudfit,
1990) or perhaps on ascending nocicep-
tive pathways, for example, at a thalamic
level (Voisin et al., 2005).
Counter to our expectation, we also
demonstrated a potent LC-mediated pro-
nociceptive action that reduced the thermal
withdrawal threshold. Although the LC is
predominantly associatedwith pain inhibi-
tion, there is some evidence to suggest that
it may also play a role in the facilitation
of chronic pain. Brightwell and Taylor
(2009) showed that the LC facilitates the
maintenance of neuropathic pain. Simi-
larlyMartins et al. (2010) reported a facili-
tatory effect of the LC on neuropathic
painmediated via themedullary dorsal re-
ticular nucleus. In addition, the second
phase behavioral responses to formalin
injection were found to be reduced after
neurotoxic LC lesions (Martin et al.,
1999). In contrast, we reported previously
that selective inhibition of the pontospi-
nal LC enhances the response to formalin
(Howorth et al., 2009b), which raises the
possibility of anatomically distinct LC ef-
fects on nociceptive processing.
By mapping of the distribution of the
transduced neurons, we demonstrated that a larger proportion of
the fluorescent neurons were located in the ventral LC and sub-
ceruleus in those experiments showing antinociceptive re-
sponses. Similarly, we found that the optic fiber placement was
deeper in experiments showing antinociceptive responses. We
A
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Figure 8. Subpopulations of LC/subceruleus neurons drive antinociception versus pronociception.A, Schematic illustrating the
position of LV-transduced neurons from rats showing antinociception (n 7, top row) and pronociception (n 4, bottom row)
overlaid on atlas sections (Paxinos andWatson, 2005). Each color represents a different animal, each dot corresponds to a neuron
in a 40m section, and dark core dots are outside the LC. Animals showing antinociception had LV-transduced LC neurons with a
ventral predominance clearly extending to the subceruleus, whereas transductionwasmainly restricted tomidcaudal LC proper in
those showing pronociceptive effects. B, Graph showing the fiber stimulation site (depth from cerebellar surface) for the prono-
ciceptive actions, which were more dorsal than those sites with antinociceptive actions (left and right, respectively, *p 0.05,
unpaired t test). C, By changing our recording protocol to allow the fiber position to be advanced beyond the first response site (by
500m), we observed a switch in the response from pronociception to antinociception (n 3). rmANOVA followed by Bonfer-
roni’s posttest, **p 0.01, *p 0.05.
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subsequently showed both pronociceptive and antinociceptive
actions in the same experiment by varying fiber depth. This sug-
gests that the pronociceptive and antinociceptive actions are me-
diated by distinct subpopulations of LC neurons, with the
antinociceptive effect originating from neurons in the ventral
region. The balance of pronociceptive versus antinociceptive ac-
tions within any given experiment was thus a function of the
distribution of the transduced neurons within the LC and of the
fiber position relative to the LC. These data support the principle
that the antinociception may be via a spinally mediated mech-
anism, because the ventral LC and subceruleus are known to
project to the dorsal horn of the spinal cord (Westlund et al.,
1983; Loughlin et al., 1986a; Howorth et al., 2009a; Bruin-
stroop et al., 2012), although it is also apparent that some of
the spinally projecting LC neurons also innervate supratento-
rial structures (Guyenet, 1980; Leanza et al., 1989; Howorth et
al., 2009a), forming a neural substrate for a multilevel influ-
ence upon pain processing. The detailed dissection of these LC
modules will require more specific transduction methods that
allow selective targeting of these subpopulations (Howorth et
al., 2009a; Osakada et al., 2011) or activation of their terminals
by focal spinal illumination.
We show here that the LC neurons are activated by noxious
heat stimulation, which is consistent with a role in the modula-
tion of nociception. Although the LC has long been known to
respond to noxious mechanical stimulation (Cedarbaum and
Aghajanian, 1976) and to prolonged thermal stimuli (Elam et al.,
1986; Hajo´s et al., 1986), we have extended this finding using the
heat ramp withdrawal response assay. With this graded stimulus,
we show that LC activation occurs just as the temperature reaches
the noxious range (i.e., as it becomes salient) immediately before
thewithdrawal response; therefore, conceptually, the LCneurons
could act to attenuate the onward transmission of the nociceptive
information.However, this could be part of an alerting or arousal
response to the stimulus as part of a facilitatory action, as has
been reported for “on cells” in the RVM (Fields et al., 1991).
The LC is implicated in the regulation of attention, sleep–
wake cycles, mood, and motivation mediated by interlinked, co-
ordinated effects across distinct neural systems (Berridge and
Waterhouse, 2003; Sara, 2009). Within this framework, we hy-
pothesize that the pronociceptive action may be mediated by a
subset of LC neurons also responsible for promoting wakefulness
and attention (Carter et al., 2010) as part of a system to focus
cognitive resources. In contrast, the antinociceptive actions may
be mediated by a distinct subset that are engaged in a different
behavioral context such as the “fight or flight” response to atten-
uate the incoming nociceptive signal to deploy defensive or es-
cape behaviors (Heinricher et al., 2009). Bidirectional actions of
the LC have been documented for other sensory modalities, in
which this is thought to improve acuity (for review, see Berridge
andWaterhouse, 2003; Sara, 2009; Sara and Bouret, 2012) as part
of a salience detectionmechanism. Given that a noxious stimulus
is by definition an event with high salience (Legrain et al., 2011),
it is perhaps not surprising that such bimodal modulation of
nociceptive responses could be demonstrated by direct activation
of the LC. This dual role of the LC may account in part for the
limited efficacy of NA reuptake inhibition in the treatment of
chronic pain (Finnerup et al., 2010), in which the net effect may
be the sum of opposing actions, and also suggests that therapeu-
tically targeting the whole LC for neuromodulation is unlikely to
yield “pure” antinociceptive actions.
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